Product Liability

Saxenda Lawsuit

Saxenda Lawsuit — Product Liability class action lawsuit

Case Overview

Saxenda is an injectable weight-loss medication containing liraglutide that was approved by the FDA on December 23, 2014, and manufactured by Novo Nordisk, a Danish multinational pharmaceutical company. The drug is prescribed in conjunction with diet and exercise for obese and overweight adults. Recent studies have found that Saxenda may increase the risk of serious health conditions including pancreatitis, pancreatic cancer, thyroid cancer, and stomach paralysis (gastroparesis).

Lawsuits against Novo Nordisk allege that the company failed to adequately warn patients about possible risks of severe stomach problems, pancreatic cancer, and other serious complications. One notable case is Jaclyn Bjorklund v. Novo Nordisk et al., where a 44-year-old woman from Louisiana claims she was severely injured after taking the drug, developing stomach problems so severe that she required emergency room visits multiple times and experienced severe vomiting that resulted in tooth loss. Currently, individual lawsuits are being filed on behalf of people who developed pancreatic cancer or pre-cancerous cell changes after taking Saxenda, with no class action lawsuits filed as of the date of this information. About 400 individuals have reported gastrointestinal injuries allegedly caused by diabetes and weight-loss drugs in this class.

Who May Qualify

You may qualify for a Saxenda lawsuit if you: were diagnosed with pancreatic cancer or pre-cancerous cell changes after taking Saxenda; developed severe stomach paralysis (gastroparesis) after using the drug; experienced other serious side effects such as acute pancreatitis or thyroid cancer; have medical records linking your condition to Saxenda use; or incurred financial or physical harm due to these side effects. Currently, lawyers are primarily filing lawsuits on behalf of individuals who developed pancreatic cancer or pre-cancerous cell changes.

Frequently Asked Questions

What legal actions can I take against Novo Nordisk?

You can file individual lawsuits against Novo Nordisk for damages related to serious side effects from Saxenda. Currently, no class action lawsuits have been filed in the Saxenda litigation, as the drug was only recently approved and health risks are now beginning to surface.

Do I need proof that Saxenda caused my harm?

Yes, you need evidence demonstrating that Saxenda caused harm. Acceptable evidence includes medical records showing your health issues, purchase receipts, laboratory test results, expert testimony, and documentation of any communication with healthcare providers or the manufacturer.

What compensation can I receive from a Saxenda lawsuit?

You may be entitled to compensation covering all current and future medical expenses related to treatment of your condition, lost wages due to inability to work, pain and suffering, and other damages related to side effects caused by Saxenda.

Related Cases

Victoza (Liraglutide) Lawsuit: Vision Loss (NAION) Claims — Product Liability class action lawsuit

Victoza (Liraglutide) Lawsuit: Vision Loss (NAION) Claims

Current
Product Liability
Victoza (liraglutide) lawsuits claim that Novo Nordisk failed to warn patients about the risk of non-arteritic anterior ischemic optic neuropathy (NAION), a condition causing sudden vision loss. Users of the GLP-1 diabetes drug allege that the manufacturer did not adequately disclose the potential eye damage risks.
B. Braun Aesculap Knee Replacement Defective Device Lawsuit — Product Liability class action lawsuit

B. Braun Aesculap Knee Replacement Defective Device Lawsuit

Current
Product Liability
A lawsuit against B. Braun alleges that its Aesculap knee replacement devices have serious design defects causing metallosis, early device failure, and complications requiring revision surgeries. The company is accused of concealing these defects from regulators while continuing to promote the device.
Bard / Becton Dickinson PowerPort Implantable Port Catheter Fracture & Injury Litigation — Product Liability class action lawsuit

Bard / Becton Dickinson PowerPort Implantable Port Catheter Fracture & Injury Litigation

Current
Product Liability
Plaintiffs allege that Bard PowerPort implantable port catheters — used in cancer patients and others requiring long-term IV access — are defectively designed and prone to fracturing, migrating, and causing life-threatening injuries including cardiac injury, pulmonary embolism, and infection.